Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 15, 2009, Pages 6279-6284

  Wang, Yun ^a   DiGiovanna, John J ^a,b   Stern, Jere B ^a   Hornyak, Thomas J ^a   Raffeld, Mark ^a   Khan, Sikandar G ^a   Oh, Kyu Seon ^a   Hollander, M Christine ^a   Dennis, Philip A ^a   Kraemer, Kenneth H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

DNA repair; Laser capture microdissection; PTEN; Skin cancer; Ultraviolet radiation

Indexed keywords

AMINO ACID; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PYRIMIDINE; PTEN PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER INVASION; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE INACTIVATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MALE; MELANOMA; NATIONAL HEALTH ORGANIZATION; POPULATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION EXPOSURE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM; AMINO ACID SEQUENCE; CELL CULTURE; CHEMISTRY; GENETICS; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELLS, CULTURED; HUMANS; MELANOMA; MUTATION; PTEN PHOSPHOHYDROLASE; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM;

EID: 65549163889     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0812401106     Document Type: Article

References (56)

1. Ries LAG, et al. (2008) SEER Cancer Statistics Review. Available at 1975-2005 http:// seer.cancer.gov/csr/1975-2005/. Accessed October 2008.
2. American Academy of Dermatology (2008) Melanoma Fact Sheet. Available at http:// www.aad.org/media/background/factsheets/fact-melanoma.html. Accessed October 2008.
3. De Gruijl FR, Van Kranen HJ, Mullenders LH (2001) UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B 63:19-27.
4. Kraemer KH (1997) Sunlight and skin cancer: Another link revealed. Proc Natl Acad Sci USA 94:11-14.
5. Armstrong BK, Kricker A (2001) The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63:8-18.
6. Scotto J, Fears TR, Kraemer KH, Fraumeni JF, Jr (1996) in Cancer Epidemiology and Prevention , eds Schottenfeld D, Fraumeni JF, Jr. (Oxford Univ Press, New York), pp. 1313-1330.
7. D'Errico M, et al. (2000) UV mutation signature in tumor suppressor genes involved in skin carcinogenesis in xeroderma pigmentosum patients. Oncogene 19:463-467.
8. Ziegler A, et al. (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90:4216-4220.
9. Ziegler A, et al. (1994) Sunburn and p53 in the onset of skin cancer. Nature 372:773-776.
10. Gilchrest BA, Eller MS, Geller AC, Yaar M (1999) The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340:1341-1348.
11. Houghton AN, Polsky D (2002) Focus on melanoma. Cancer Cell 2:275-278.
12. Whiteman DC, et al. (2006) Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 24:3172-3177.
13. Kraemer KH, Lee MM, Andrews AD, Lambert WC (1994) The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130:1018-1021.
14. Kusewitt DF, Applegate LA, Ley RD (1991) Ultraviolet radiation-induced skin tumors in a South American opossum (Monodelphis domestica). Vet Pathol 28:55-65.
15. Setlow RB, Woodhead AD, Grist E (1989) Animal model for ultraviolet radiation-induced melanoma: Platyfish-swordtail hybrid. Proc Natl Acad Sci USA 86:8922-8926.
16. Noonan FP, et al. (2001) Neonatal sunburn and melanoma in mice. Nature 413:271-272.
17. Friedberg EC, et al. (2006) DNA Repair and Mutagenesis (ASM Press, Washington, D.C.).
18. Seidman MM, Bredberg A, Seetharam S, Kraemer KH (1987) Multiple point mutations in a shuttle vector propagated in human cells: Evidence for an error-prone DNA polymerase activity. Proc Natl Acad Sci USA 84:4944-4948.
19. Ruenger TM, DiGiovanna JJ, Kraemer KH (2008) in Fitzpatrick's Dermatology in General Medicine , eds Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ (McGraw Hill, New York), pp. 1311-1325.
20. Hocker T, Tsao H (2007) Ultraviolet radiation and melanoma: A systematic review and analysis of reported sequence variants. Hum Mutat 28:578-588.
21. Lü bbe J, Reichel M, Burg G, Kleihues P (1994) Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol 102:819-821.
22. Sanger Institute (2008) Catalogue of Somatic Mutations in Cancer. Available at http:// www.sanger.ac.uk/perl/genetics/CGP/cosmic. Accessed July 2008.
23. Baker SJ (2007) PTEN enters the nuclear age. Cell 128:25-28.
24. Abdel-Rahman MH, et al. (2006) High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma. J Clin Oncol 24:288-295.
25. Bonneau D, Longy M (2000) Mutations of the human PTEN gene. Hum Mutat 16:109-122.
26. Mikhail M, et al. (2005) PTEN expression in melanoma: Relationship with patient survival, Bcl-2 expression, and proliferation. Clin Cancer Res 11:5153-5157.
27. Slipicevic A, et al. (2005) Expression of activated Akt and PTEN in malignant melanomas: Relationship with clinical outcome. Am J Clin Pathol 124:1-9.
28. Curtin JA, et al. (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135-2147.
29. Carli P, et al. (2004) Improvement of malignant/benign ratio in excised melanocytic lesions in the ''dermoscopy era'': A retrospective study 1997-2001. Br J Dermatol 150:687-692.
30. Sztramska A, Dymerska D, Chwirot BW (2008) Skin layer-specific Melan-A expression during progression of human cutaneous melanoma: Implications for diagnostic applications of the marker. Melanoma Res 18:259-267.
31. Dumstorf CA, et al. (2006) Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer. Proc Natl Acad Sci USA 103:18083-18088.
32. Bishop JM (1987) The molecular genetics of cancer. Science 235:305-311.
33. Levy DD, Saijo M, Tanaka K, Kraemer KH (1995) Expression of a transfected DNA repair gene (XPA ) in xeroderma pigmentosum group A cells restores normal DNA repair and mutagenesis of UV-treated plasmids. Carcinogenesis 16:1557-1564.
34. Wang Y, et al. (2007) Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations. Cancer Res 67:3018-3026.
35. Brooks PJ (2007) The case for 8,5 -cyclopurine-2-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience 145:1407-1417.
36. Myers MP, et al. (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95:13513-13518.
37. Sulis ML, Parsons R (2003) PTEN: From pathology to biology. Trends Cell Biol 13:478 - 483.
38. Dai DL, Martinka M, Li G (2005) Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases. J Clin Oncol 23:1473-1482.
39. Kanaya T, et al. (2005) Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population. Am J Clin Pathol 124:89-96.
40. Guldberg P, et al. (1997) Disruption of the MMAC1 /PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57:3660-3663.
41. Tsao H, Zhang X, Benoit E, Haluska FG (1998) Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 16:3397-3402.
42. Tsao H, Mihm MC, Jr, Sheehan C (2003) PTEN expression in normal skin, acquired mela-nocytic nevi, and cutaneous melanoma. J Am Acad Dermatol 49:865-872.
43. Goel VK, Lazar AJ, Warneke CL, Redston MS, Haluska FG (2006) Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma. J Invest Dermatol 126:154-160.
44. Mirmohammadsadegh A, et al. (2006) Epigenetic silencing of the PTEN gene in melanoma. Cancer Res 66:6546-6552.
45. Birck A, Ahrenkiel V, Zeuthen J, Hou-Jensen K, Guldberg P (2000) Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies. JInvestDermatol 114:277-280.
46. Celebi JT, Shendrik I, Silvers DN, Peacocke M (2000) Identification of PTEN mutations in metastatic melanoma specimens. J Med Genet 37:653-657.
47. Daniotti M, et al. (2004) BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene 23:5968-5977.
48. Jonsson G, et al. (2007) Genomic profiling of malignant melanoma using tiling-resolution arrayCGH. Oncogene 26:4738-4748.
49. Poetsch M, Dittberner T, Woenckhaus C (2001) PTEN/MMAC1 in malignant melanoma and its importance for tumor progression. Cancer Genet Cytogenet 125:21-26.
50. Reifenberger J, et al. (2000) Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Virchows Arch 436:487-493.
51. Tsao H, Zhang X, Fowlkes K, Haluska FG (2000) Relative reciprocity of NRAS and PTEN/ MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res 60:1800-1804.
52. Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241-250.
53. Shen WH, et al. (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128:157-170.
54. Muhr D, Wagner T, Oefner PJ (2002) Polymerase chain reaction fidelity and denaturing high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 782:105-110.
55. Leslie NR, Gray A, Pass I, Orchiston EA, Downes CP (2000) Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: Differential effects of C-terminal deletion on signaling pathways downstream of phosphoinositide 3-kinase. Bio-chem J 346 Pt 3:827-833.
56. Brognard J, Clark AS, Ni Y, Dennis PA (2001) Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61:3986-3997.